Chiral analysis of ibuprofen residues in water and sediment

Analytical Letters

Volumn 42, Issue 12, 2009, Pages 1747-1760

  Ali, Imran ^a   Singh, Prashant ^b   Aboul Enein, Hassan Y ^c   Sharma, Bhavtosh ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b DAV PG College   (India)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chiral drugs residues; Chromatography; Environmental matrices; Ibuprofen; Water resources

Indexed keywords

EID: 70449412950     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710903060768     Document Type: Review

References (52)

1. Aboul-Enein, H. Y., and I. Ali. 2003. Chiral Separations by Liquid Chromatography and Related Technologies. New York: Marcel Dekker.
2. Ali, I., and H. Y. Aboul-Enein. 2004. Chiral Pollutants: Distribution, Toxicity, and Analysis by Chromatography and Capillary Electrophoresis. Chichester, West Sussex, UK: John Wiley and Sons.
3. Ali, I., and H. Y. Aboul-Enein. 2006. Instrumental Methods in Metal Ions Speciation: Chromatography, Capillary Electrophoresis, and Electrochemistry. New York: Taylor & Francis.
4. Ali, I., and C. K. Jain. 2005. Wastewater treatment and recycling technologies. In Water Encyclopedia: Domestic, Municipal, and Industrial Water Supply and Waste Disposal. New York: John Wiley & Sons.
5. Antonic, J., and E. Heath. 2007. Determination of NSAIDs in river sediment samples. Anal. Bioanal. Chem. 387: 1337-1342.
6. Baillie, T. A., W. J. Adams, D. G. Kaiser, L. S. Olanoff, G. W. Halstead, H. Harpootlian, and G. J. Van Giessen. 1989. Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J. Pharmacol. Exp. Ther. 249: 517-523.
7. Basheer, C., H. G. Chong, T. M. Hii, and H. K. Lee. 2007. Application of porous membrane-protected micro-solid-phase extraction combined with HPLC for the analysis of acidic drugs in waste water. Anal. Chem. 79: 6845-6850.
8. Bound, J. P., and N. Voulvoulis. 2006. Predicted and measured concentrations for selected pharmaceuticals in UK rivers: Implications for risk assessment. Water Res. 40: 2885-2892.
9. Brun, G. L., M. Bernier, R. Losier, K. Doe, P. Jackman, and H. B. Lee. 2006. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 25: 2163-2176.
10. Brune, K. 2007. Persistence of NSAIDs at effective sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr. Med. Res. Opin. 23: 2985-2995.
11. Buser, H. R., T. Poiger, and M. D. Muller. 1999. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewaters. Environ. Sci. Technol. 33: 2529-2535.
12. Carvalho, P. O., Q. B. Cass, S. A. Calafatti, F. J. Contesini, and R. Bizaco. 2006.Review: Alternatives for the separation of drug enantiomers: Ibuprofen as a model compound. J. Braz. Chem. Eng. 23: 291-300.
13. Debska, J., A. Kot-Wasik, and J. Namiesnik. 2005. Determination of nonsteroidal anti-inflammatory drugs in water samples using liquid chromatography coupled with diode-array detector and mass spectrometry. J. Sep. Sci. 28: 2419-2426.
14. Farré, M. L., I. Ferrer, A. Ginebreda, M. Figueras, L. Olivella, L. Tirapu, M. Vilanova, and D. Barceló. 2001. Determination of drugs in surface water and waste water samples by liquid chromatography-mass spectrometry: Methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A. 938: 187-197.
15. Gibson, R., E. Becerril-Bravo, V. Silva-Castro, and B. Jiménez. 2007. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in waste waters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry. J. Chromatogr. A 1169: 31-49.
16. Gros, M., M. Petrovic, and D. Barcelo. 2007. Waste water treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (northeast Spain). Environ. Toxicol. Chem. 26: 1553-1562.
17. Gross, B., J. Montgomery-Brown, A. Naumann, and M. Reinhard. 2004. Occurrence and fate of pharmaceuticals and alkyl phenol ethoxylate metabolites in an effluent-dominated river and wetland. Environ. Toxicol. Chem. 23: 2074-2083.
18. Hernando, M. D., E. Heath, M. Petrovic, and D. Barcel_o. 2006. Trace-level determination of pharmaceutical residues by LC-MS=MS in natural and treated waters: A pilot-survey study. Anal. Bioanal. Chem. 385: 985-991.
19. Hilton, M. J., and K. V. Thomas. 2003. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 1015: 129-141.
20. Hutt, A. J., and J. Caldwell. 1983. The metabolic chiral inversion of 2-arylpropionic acids: A novel route with pharmaceutical consequences. J. Pharm. Pharmacol. 35: 693-704.
21. Kosjek, T., E. Heath, and A. Krbavcic. 2005. Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ. Int. 31: 679-685.
22. Kümmerer, K., A. Al-Ahmadi, B. Bertram, and M. Wiebler. 2000. Biodegradability of antineoplastic compounds in screening tests: Influence of glucosidation and of stereochemistry. Chemosphere 40: 767-773.
23. Lewis, D. L., A. W. Garrison, K. E. Wommack, A. Whittemore, P. Steudler, and J. Melillo 1999. Influence of environmental changes on degradation of chiral pollutants in soil. Nature 401: 898-901.
24. Lin, A. Y., and M. Reinhard. 2005. Photodegradation of common environmental pharmaceuticals and estrogens in river water. Environ. Toxicol. Chem. 24: 1303-1309.
25. Lin, W. C., H. C. Chen, and W. H. Ding. 2005. Determination of pharmaceutical residues in waters by solid-phase extraction and large-volume on-line derivatization with gas chromatography-mass spectrometry. J. Chromatogr. A 1065: 279-285.
26. Lockwood, G. F., K. S. Albert, W. R. Gillespie, G. G. Bole, T. M. Harkcom, G. J. Szpunar, and J. G. Wagner. 1983. Pharmacokinetics of ibuprofen in man, I: Free and total area=dose relationship. Clin. Pharmacol. Ther. 34: 97-103.
27. Löffler, D., and T. A. Ternes. 2003. Determination of acidic pharmaceuticals, antibiotics, and ivermection in river sediment using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1021: 133-144.
28. Moeder, M., S. Schrader, M. Winkler, and P. Popp. 2000. Solid-phase microextraction-gas chromatography-mass spectrometry of biologically active substances in water samples. J. Chromatogr. A 873: 95-106.
29. Moldovan, Z., G. Schmutzer, F. Tusa, R. Calin, and A. C. Alder. 2007. An overview of pharmaceuticals and personal care products contamination along the River Somes watershed, Romania. J. Environ. Monit. 9: 986-993.
30. Nakada, N., K. Komori, and Y. Suzuki. 2005. Occurrence and fate of antiinflammatory drugs in wastewater treatment plants in Japan. Environ. Sci. 12: 359-369.
31. Nakada, N., T. Tanishima, H. Shinohara, K. Kiri, and H. Takada. 2006. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 40: 3297-3303.
32. Nebot, C., S. W. Gibb, and K. G. Boyd. 2007. Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry. Anal Chim. Acta 598: 87-94.
33. Ollers, S., H. P. Singer, P. Fässler, and S. R. Müller. 2001. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng=l level in surface and waste water. J. Chromatogr. A 911: 225-234.
34. Pedrouzo, M., S. Reverte, F. Borrull, E. Pocurull, and R. M. Marce. 2007. Pharmaceutical determination in surface and waste waters using high-performance liquid chromatography-(electrospray)-mass spectrometry. J. Sep. Sci. 30: 297-303.
35. Rice, S. L., and S. Mitra. 2007. Micowave-assisted solvent extraction of solid matrices and subsequent detection of pharmaceuticals and personal care products (PPCPs) using gas chromatography-mass spectrometry. Anal. Chim. Acta 589: 125-132.
36. Roberts, P. H., and K. V. Thomas. 2006. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne Catchment. Sci. Total Environ. 356: 143-153.
37. Santos, J. L., I. Aparicio, and E. Alonso. 2007. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants: A case study: Seville city (Spain). Environ. Int. 33: 596-601.
38. Scheytt, T., P. Mersmann, R. Lindstädt, and T. Heberer. 2005. Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere 60: 245-253.
39. Soliman, M. A., J. A. Pedersen, H. Park, A. Castaneda-Jimenez, M. K. Stenstrom, and I. H. Suffet. 2007. Human pharmaceuticals, antioxidants, and plasticizers, in wastewater treatment plant and water reclamation plant effluents. Water Environ. Res. 79: 156-167.
40. Stafiej, A., K. Pyrzynska, and F. Regan. 2007. Determination of antiinflammatory drugs and estrogens in water by HPLC with UV detection. J. Sep. Sci. 30: 985-991.
41. Tauxe-Wuersch, A., L. F. De Alencastro, D. Grandjean, and J. Tarradellas. 2005. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 39: 1761-1772.
42. Ternes, T. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32: 3245-3260.
43. Thomas, P. M., and G. D. Foster. 2004. Determination of nonsteroidal anti-inflammatory drugs, caffeine, and triclosan in waste water by gas chromatography-mass spectrometry. J. Environ. Sci. Health A: Tox. Hazard Subst. Environ. Eng. 39: 1969-1978.
44. Tixier, C., H. P. Singer, S. Oellers, and S. R. Müller. 2003. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 37: 1061-1068.
45. Togola, A., and H. Budzinski. 2007. Analytical development for analysis of pharmaceuticals in water samples by SPE and GC-MS. Anal. Bioanal. Chem. 388: 627-635.
46. Verenitch, S. S., C. J. Lowe, and A. Mazumder. 2006. Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography-ion trap tandem mass spectrometry. J. Chromatogr. A 1116: 193-203.
47. Weigel, S., J. Kuhlmann, and H. Hühnerfuss. 2002. Drugs and personal care products as ubiquitous pollutants: Occurrence and distribution of clofibric acid, caffeine, and DEET in the North Sea. Sci. Total Environ. 295: 131-141.
48. Williams, A. 1996. Opportunities for chiral agrochemicals. Pestic. Sci. 46: 3-9.
49. Winkler, M., J. R. Lawrence, and T. R. Neu. 2001. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res. 35: 3197-3205.
50. Yu, Z., S. Peldszus, and P. M. Huck. 2007. Optimizing gas chromatographic-mass spectrometric analysis of selected pharmaceuticals and endocrine disrupting substances in water using factorial experimental design. J. Chromatogr. A 1148: 65-77.
51. Zhang, S., Q. Zhang, S. Darisaw, O. Ehie, and G. Wang. 2007. Simutaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuiticals and personal care products (PPCBs) in Mississippi River water, in New Orleans, Louisiana, USA. Chemosphere 66: 1057-1069.
52. Zorita, S., T. Barri, and L. Mathiasson. 2007. A novel hollow-fibre microporous membrane liquid-liquid extraction for determination of free 4-isobutylacetophenone concentration at ultra trace level in environmental aqueous samples. J. Chromatogr. A 1157: 30-37.